170 related articles for article (PubMed ID: 31876581)
1. IDH2 Mutation Analysis in Undifferentiated and Poorly Differentiated Sinonasal Carcinomas for Diagnosis and Clinical Management.
Riobello C; López-Hernández A; Cabal VN; García-Marín R; Suárez-Fernández L; Sánchez-Fernández P; Vivanco B; Blanco V; López F; Franchi A; Llorente JL; Hermsen MA
Am J Surg Pathol; 2020 Mar; 44(3):396-405. PubMed ID: 31876581
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Detection and Molecular Characterization of IDH-mutant Sinonasal Undifferentiated Carcinomas.
Mito JK; Bishop JA; Sadow PM; Stelow EB; Faquin WC; Mills SE; Krane JF; French CA; Fletcher CDM; Hornick JL; Sholl LM; Jo VY
Am J Surg Pathol; 2018 Aug; 42(8):1067-1075. PubMed ID: 29683816
[TBL] [Abstract][Full Text] [Related]
3. The role of a monoclonal antibody 11C8B1 as a diagnostic marker of IDH2-mutated sinonasal undifferentiated carcinoma.
Dogan S; Frosina D; Fayad M; de Oliveira TB; Alemar B; Rosenblum M; Tang LH; Hameed M; Xu B; Ghossein RA; Chute DJ; Weigelt B; Jungbluth AA
Mod Pathol; 2019 Feb; 32(2):205-215. PubMed ID: 30206411
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation-based classification of sinonasal undifferentiated carcinoma.
Dogan S; Vasudevaraja V; Xu B; Serrano J; Ptashkin RN; Jung HJ; Chiang S; Jungbluth AA; Cohen MA; Ganly I; Berger MF; Momeni Boroujeni A; Ghossein RA; Ladanyi M; Chute DJ; Snuderl M
Mod Pathol; 2019 Oct; 32(10):1447-1459. PubMed ID: 31186531
[TBL] [Abstract][Full Text] [Related]
5. Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma.
Jo VY; Chau NG; Hornick JL; Krane JF; Sholl LM
Mod Pathol; 2017 May; 30(5):650-659. PubMed ID: 28084339
[TBL] [Abstract][Full Text] [Related]
6. Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas.
Dogan S; Chute DJ; Xu B; Ptashkin RN; Chandramohan R; Casanova-Murphy J; Nafa K; Bishop JA; Chiosea SI; Stelow EB; Ganly I; Pfister DG; Katabi N; Ghossein RA; Berger MF
J Pathol; 2017 Aug; 242(4):400-408. PubMed ID: 28493366
[TBL] [Abstract][Full Text] [Related]
7. IDH1/2 Mutations in Sinonasal Undifferentiated Carcinomas : Previously Undescribed IDH2 R172K and R140x Variants.
Kakkar A; Rathor A; Ashraf SF; Singh V; Sikka K; Jain D
Am J Surg Pathol; 2022 Sep; 46(9):1284-1290. PubMed ID: 35486703
[TBL] [Abstract][Full Text] [Related]
8. IDH2 R172 Mutations Across Poorly Differentiated Sinonasal Tract Malignancies: Forty Molecularly Homogenous and Histologically Variable Cases With Favorable Outcome.
Glöss S; Jurmeister P; Thieme A; Schmid S; Cai WY; Serrette RN; Perner S; Ribbat-Idel J; Pagenstecher A; Bläker H; Keber U; Stadelmann C; Zechel S; Johann PD; Hasselblatt M; Paulus W; Thomas C; Dohmen H; Baumhoer D; Frank S; Agaimy A; Schüller U; Vasudevaraja V; Snuderl M; Liu CZ; Pfister DG; Jungbluth AA; Ghossein RA; Xu B; Capper D; Dogan S
Am J Surg Pathol; 2021 Sep; 45(9):1190-1204. PubMed ID: 34265800
[TBL] [Abstract][Full Text] [Related]
9. IDH2 -Mutated Sinonasal Tumors: A Review.
Alzumaili B; Sadow PM
Adv Anat Pathol; 2023 Mar; 30(2):104-111. PubMed ID: 36537260
[TBL] [Abstract][Full Text] [Related]
10. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
[TBL] [Abstract][Full Text] [Related]
11. Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients.
Chotirat S; Thongnoppakhun W; Promsuwicha O; Boonthimat C; Auewarakul CU
J Hematol Oncol; 2012 Mar; 5():5. PubMed ID: 22397365
[TBL] [Abstract][Full Text] [Related]
12. SMARCA4/BRG1-Deficient Sinonasal Carcinoma.
Kakkar A; Ashraf SF; Rathor A; Adhya AK; Mani S; Sikka K; Jain D
Arch Pathol Lab Med; 2022 Sep; 146(9):1122-1130. PubMed ID: 34871352
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of IDH2 hotspot mutations in cancer and immunohistochemical detection of R172K, R172G, and R172M variants.
Dogan S; Frosina D; Geronimo JA; Hernandez E; Mohanty A; Bale T; Hechtman JF; Arcila ME; Hameed MR; Jungbluth AA
Hum Pathol; 2020 Dec; 106():45-53. PubMed ID: 33017591
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of IDH1 and IDH2 mutations in patients with acute myeloid leukemia].
Jia ZX; Zhou M; Chao HY; Lu XZ; Zhang R; Cen L; Xiao R; Jiang NK
Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):397-401. PubMed ID: 22781800
[TBL] [Abstract][Full Text] [Related]
15. High-grade sinonasal carcinomas and surveillance of differential expression in immune related transcriptome.
Bell D; Bell A; Ferrarotto R; Glisson B; Takahashi Y; Fuller G; Weber R; Hanna E
Ann Diagn Pathol; 2020 Dec; 49():151622. PubMed ID: 32927372
[TBL] [Abstract][Full Text] [Related]
16. Isoforms of IDH in breast carcinoma: IDH2 as a potent prognostic factor associated with proliferation in estrogen-receptor positive cases.
Minemura H; Takagi K; Sato A; Yamaguchi M; Hayashi C; Miki Y; Harada-Shoji N; Miyashita M; Sasano H; Suzuki T
Breast Cancer; 2021 Jul; 28(4):915-926. PubMed ID: 33713004
[TBL] [Abstract][Full Text] [Related]
17. IDH1 and IDH2 mutations in lung adenocarcinomas: Evidences of subclonal evolution.
Rodriguez EF; De Marchi F; Lokhandwala PM; Belchis D; Xian R; Gocke CD; Eshleman JR; Illei P; Li MT
Cancer Med; 2020 Jun; 9(12):4386-4394. PubMed ID: 32333643
[TBL] [Abstract][Full Text] [Related]
18. Molecular investigation of isocitrate dehydrogenase gene (IDH) mutations in gliomas: first report of IDH2 mutations in Indian patients.
Das BR; Tangri R; Ahmad F; Roy A; Patole K
Asian Pac J Cancer Prev; 2013; 14(12):7261-4. PubMed ID: 24460285
[TBL] [Abstract][Full Text] [Related]
19. SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity.
Laco J; Chmelařová M; Vošmiková H; Sieglová K; Bubancová I; Dundr P; Němejcová K; Michálek J; Čelakovský P; Mottl R; Sirák I; Vošmik M; Ryška A
Pathol Res Pract; 2017 Feb; 213(2):133-142. PubMed ID: 28069272
[TBL] [Abstract][Full Text] [Related]
20. Genomic Profiling Identifies Association of
Zhu GG; Nafa K; Agaram N; Zehir A; Benayed R; Sadowska J; Borsu L; Kelly C; Tap WD; Fabbri N; Athanasian E; Boland PJ; Healey JH; Berger MF; Ladanyi M; Hameed M
Clin Cancer Res; 2020 Jan; 26(2):419-427. PubMed ID: 31615936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
